Related references
Note: Only part of the references are listed.Comparative effectiveness of cefazolin versus cloxacillin as definitive antibiotic therapy for MSSA bacteraemia: results from a large multicentre cohort study
Anthony D. Bai et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Improved Outcome with Early Rifampicin Combination Treatment in Methicillin-Sensitive Staphylococcus aureus Bacteraemia with a Deep Infection Focus - A Retrospective Cohort Study
Erik Forsblom et al.
PLOS ONE (2015)
Antistaphylococcal penicillins versus cephalosporins for definitive treatment of meticillin-susceptible Staphylococcus aureus bacteraemia: A systematic review and meta-analysis
Konstantinos Z. Vardakas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Relative efficacy of cefuroxime versus dicloxacillin as definitive antimicrobial therapy in methicillin-susceptible Staphylococcus aureus bacteraemia: a propensity-score adjusted retrospective cohort study
Jon Bjarke Rasmussen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
In Vivo Effects of Cefazolin, Daptomycin, and Nafcillin in Experimental Endocarditis with a Methicillin-Susceptible Staphylococcus aureus Strain Showing an Inoculum Effect against Cefazolin
Esteban C. Nannini et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Telephone Consultation Cannot Replace Bedside Infectious Disease Consultation in the Management of Staphylococcus aureus Bacteremia
E. Forsblom et al.
CLINICAL INFECTIOUS DISEASES (2013)
Effectiveness of penicillin, dicloxacillin and cefuroxime for penicillin-susceptible Staphylococcus aureus bacteraemia: a retrospective, propensity-score-adjusted casecontrol and cohort analysis
Jette Lindbjerg Nissen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Is Cefazolin Inferior to Nafcillin for Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia?
Shinwon Lee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia?
M. Paul et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Predisposing factors, disease progression and outcome in 430 prospectively followed patients of healthcare- and community-associated Staphylococcus aureus bacteraemia
E. Forsblom et al.
JOURNAL OF HOSPITAL INFECTION (2011)
Clinical management of Staphylococcus aureus bacteraemia
Guy E. Thwaites et al.
LANCET INFECTIOUS DISEASES (2011)
Inoculum Effect with Cefazolin among Clinical Isolates of Methicillin-Susceptible Staphylococcus aureus: Frequency and Possible Cause of Cefazolin Treatment Failure
Esteban C. Nannini et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Mortality of S. aureus bacteremia and infectious diseases specialist consultation - A study of 521 patients in Germany
Siegbert Rieg et al.
JOURNAL OF INFECTION (2009)
Course and outcome of Staphylococcus aureus bacteraemia:: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre
C Kaech et al.
CLINICAL MICROBIOLOGY AND INFECTION (2006)
Levofloxacin does not decrease mortality in Staphylococcus aureus bacteraemia when added to the standard treatment:: a prospective and randomized clinical trial of 381 patients
E Ruotsalainen et al.
JOURNAL OF INTERNAL MEDICINE (2006)
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
MM Levy et al.
CRITICAL CARE MEDICINE (2003)
Share Paper
